The MAA is pleased to share with you that a clinical trial is now open for Australian participation. It will potentially offer an additional treatment pathway for myasthenia gravis patients.
Please explore more details via the link provided. If you may be willing to participate, speak to your treating neurologist about progressing to the next step. The number of trial sites are expected to increase.
Here is the link to the website:
MyClad Study | Generalised myasthenia gravis (gMG)